265 related articles for article (PubMed ID: 10430217)
1. Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. Multicenter AIDS Cohort Study.
Jacobson LP; Yamashita TE; Detels R; Margolick JB; Chmiel JS; Kingsley LA; Melnick S; Muñoz A
J Acquir Immune Defic Syndr; 1999 Aug; 21 Suppl 1():S34-41. PubMed ID: 10430217
[TBL] [Abstract][Full Text] [Related]
2. Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination anti-retroviral therapy.
Grulich AE; Li Y; McDonald AM; Correll PK; Law MG; Kaldor JM
AIDS; 2001 Mar; 15(5):629-33. PubMed ID: 11317001
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Kaposi's sarcoma and HHV-8 seroprevalence among homosexual men with known dates of HIV seroconversion. Italian Seroconversion Study.
Rezza G; Dorrucci M; Serraino D; Andreoni M; Giuliani M; Zerboni R; Sarmati L; Colangeli V; Salassa B; Monini P; Ensoli B; Pezzotti P
AIDS; 2000 Jul; 14(11):1647-53. PubMed ID: 10983652
[TBL] [Abstract][Full Text] [Related]
4. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.
International Collaboration on HIV and Cancer
J Natl Cancer Inst; 2000 Nov; 92(22):1823-30. PubMed ID: 11078759
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's sarcoma and non-Hodgkin's lymphoma incidence trends in AIDS Clinical Trial Group study participants.
Rabkin CS; Testa MA; Huang J; Von Roenn JH
J Acquir Immune Defic Syndr; 1999 Aug; 21 Suppl 1():S31-3. PubMed ID: 10430216
[TBL] [Abstract][Full Text] [Related]
6. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998.
Eltom MA; Jemal A; Mbulaiteye SM; Devesa SS; Biggar RJ
J Natl Cancer Inst; 2002 Aug; 94(16):1204-10. PubMed ID: 12189223
[TBL] [Abstract][Full Text] [Related]
7. Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy.
Jones JL; Hanson DL; Dworkin MS; Jaffe HW
J Acquir Immune Defic Syndr; 2000 Jul; 24(3):270-4. PubMed ID: 10969352
[TBL] [Abstract][Full Text] [Related]
8. Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons. Adult/Adolescent Spectrum of HIV Disease Project Group.
Jones JL; Hanson DL; Dworkin MS; Ward JW; Jaffe HW
J Acquir Immune Defic Syndr; 1999 Aug; 21 Suppl 1():S11-7. PubMed ID: 10430212
[TBL] [Abstract][Full Text] [Related]
9. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
10. Opportunistic malignancies and the acquired immunodeficiency syndrome.
Mueller N; Hatzakis A
Princess Takamatsu Symp; 1987; 18():159-71. PubMed ID: 3506539
[TBL] [Abstract][Full Text] [Related]
11. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. Swiss HIV Cohort Study.
Ledergerber B; Telenti A; Egger M
BMJ; 1999 Jul; 319(7201):23-4. PubMed ID: 10390454
[No Abstract] [Full Text] [Related]
12. Changes in Clinical Context for Kaposi's Sarcoma and Non-Hodgkin Lymphoma Among People With HIV Infection in the United States.
Yanik EL; Achenbach CJ; Gopal S; Coghill AE; Cole SR; Eron JJ; Moore RD; Mathews WC; Drozd DR; Hamdan A; Ballestas ME; Engels EA
J Clin Oncol; 2016 Sep; 34(27):3276-83. PubMed ID: 27507879
[TBL] [Abstract][Full Text] [Related]
13. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
Gingues S; Gill MJ
HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.
Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V
AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767
[TBL] [Abstract][Full Text] [Related]
15. Kaposi's sarcoma and non-Hodgkin's lymphoma in European AIDS cases. No excess risk of Kaposi's sarcoma in Mediterranean countries.
Casabona J; Melbye M; Biggar RJ
Int J Cancer; 1991 Jan; 47(1):49-53. PubMed ID: 1985878
[TBL] [Abstract][Full Text] [Related]
16. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma.
Engels EA; Biggar RJ; Marshall VA; Walters MA; Gamache CJ; Whitby D; Goedert JJ
AIDS; 2003 Aug; 17(12):1847-51. PubMed ID: 12891072
[TBL] [Abstract][Full Text] [Related]
17. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma.
Renwick N; Halaby T; Weverling GJ; Dukers NH; Simpson GR; Coutinho RA; Lange JM; Schulz TF; Goudsmit J
AIDS; 1998 Dec; 12(18):2481-8. PubMed ID: 9875587
[TBL] [Abstract][Full Text] [Related]
18. Combination antiretroviral therapy and incidence of AIDS-related malignancies.
Buchbinder SP; Holmberg SD; Scheer S; Colfax G; O'Malley P; Vittinghoff E
J Acquir Immune Defic Syndr; 1999 Aug; 21 Suppl 1():S23-6. PubMed ID: 10430214
[TBL] [Abstract][Full Text] [Related]
19. Kaposi's sarcoma and human herpesvirus 8 infection do not protect HIV-1 infected homosexual men from AIDS dementia complex.
Renwick N; Weverling GJ; Halaby T; Portegies P; Bakker M; Schulz TF; Goudsmit J
AIDS; 2001 Nov; 15(16):2165-9. PubMed ID: 11684936
[TBL] [Abstract][Full Text] [Related]
20. Incidence of human immunodeficiency virus-related and nonrelated malignancies in a large cohort of homosexual men.
Lyter DW; Bryant J; Thackeray R; Rinaldo CR; Kingsley LA
J Clin Oncol; 1995 Oct; 13(10):2540-6. PubMed ID: 7595705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
